Открытое овальное окно и мигрень у пациентов, перенёсших ишемический инсульт: распространённость, патогенетическая взаимосвязь, влияние эндоваскулярного закрытия

Автор: Белопасова А.В., Чечеткин А.О., Мережко В.Д.

Журнал: Клиническая практика @clinpractice

Статья в выпуске: 3 т.15, 2024 года.

Бесплатный доступ

Обоснование. Мигрень - хроническое нейрососудистое заболевание с высокой распространённостью и медико-социальной значимостью. Несмотря на более чем полувековую историю изучения заболевания, патогенез мигрени до конца не раскрыт. Результаты отдельных исследований демонстрируют взаимосвязь мигрени с наличием открытого овального окна и шунтирующего кровотока справа налево. Цель исследования - уточнение распространённости и клинических характеристик мигрени, а также влияния эндоваскулярной установки окклюдера открытого овального окна на течение мигрени в когорте пациентов, перенёсших ишемический инсульт по механизму парадоксальной эмболии вследствие функционально значимого открытого овального окна.

Еще

Открытое овальное окно, мигрень, мигрень с аурой, ишемический инсульт, парадоксальная эмболия, право-левый шунт, установка окклюдера овального окна

Короткий адрес: https://sciup.org/143183420

IDR: 143183420 | DOI: 10.17816/clinpract634497

Список литературы Открытое овальное окно и мигрень у пациентов, перенёсших ишемический инсульт: распространённость, патогенетическая взаимосвязь, влияние эндоваскулярного закрытия

GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259. EDN: YGEVZQ doi: 10.1016/S0140-6736(17)32154-2
Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4):631–649. doi: 10.1016/j.ncl.2019.06.001
Hara H, Virmani R, Ladich E, et al. Patent foramen ovale: Current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005;46(9):1768–1776. doi: 10.1016/j.jacc.2005.08.038
Каршиева А.Р., Чечеткин А.О., Белопасова А.В., Добрынина Л.А. Диагностические критерии определения вида право-левого шунта при контрастной транскраниальной доплерографии у молодых пациентов с ишемическим острым нарушением мозгового кровообращения // Российский неврологический журнал. 2023. Т. 28, № 2. С. 38–45. [Karshieva AR, Chechetkin AO, Belopasova AV, Dobrynina LA. Diagnostic criteria for determining the type of the right-to-left shunt using contrast-enhanced transcranial doppler ultrasound in young patients with ischemic stroke/transient ischemic attack. Russ Neurolog J. 2023;28(2):38–45]. EDN: IQBLWG doi: 10.30629/2658-7947-2023-28-2-38-45
Jauss M, Zanette E. Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis. 2000;10(6):490–496. doi: 10.1159/000016119
Del SM, Angeli S, Leandri M, et al. Migraine with aura and rightto- left shunt on transcranial Doppler: A case-control study. Cerebrovasc Dis. 1998;8:327–330. doi: 10.1159/000015875
Wammes van der Heijden EA, Tijssen CC, Egberts AC. Right-to-left shunt and migraine: The strength of the relationship. Cephalalgia. 2006;26(2):208–213. doi: 10.1111/j.1468-2982.2005.01024.x
Ben-Assa E, Rengifo-Moreno P, Al-Bawardy R, et al. Effect of residual interatrial shunt on migraine burden after transcatheter closure of patent foramen ovale. JACC Cardiovasc Interv. 2020;13(3):293–302. doi: 10.1016/j.jcin.2019.09.042
Mas JL, Guillon B, Charles-Nelson A, et al.; CLOSE investigators. Patent foramen ovale closure in stroke patients with migraine in the CLOSE trial. The CLOSE-MIG study. Eur J Neurol. 2021;28(8):2700–2707. doi: 10.1111/ene.14892
Tobis MJ, Azarbal B. Does patent foramen ovale promote cryptogenic stroke and migraine headache? Tex Heart Inst J. 2005;32(3):362–365.
Wilmshurst PT. Migraine with aura and persistent foramen ovale. Eye (Lond). 2018;32(2):184–188. doi: 10.1038/eye.2017.269
West BH, Noureddin N, Mamzhi Y, et al. Frequency of patent foramen ovale and migraine in patients with cryptogenic stroke. Stroke. 2018;49(5):1123–1128. EDN: TJRSYG doi: 10.1161/STROKEAHA.117.020160
Sacco S, Harriott AM, Ayata C, et al. Microembolism and other links between migraine and stroke: Clinical and pathophysiologic update. Neurology. 2023;100(15):716–726. doi: 10.1212/WNL.0000000000201699
Borgdorff P, Tangelder GJ. Migraine: Possible role of shear-induced platelet aggregation with serotonin release. Headache. 2012;52(8):1298–1318. EDN: RKTMTR doi: 10.1111/j.1526-4610.2012.02162.x
Takano T, Tian GF, Peng W, et al. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci. 2007;10(6):754–762. doi: 10.1038/nn1902
Dalkara T, Nozari A, Moskowitz MA. Migraine aura pathophysiology: The role of blood vessels and microembolisation. Lancet Neurol. 2010;9(3):309–317. doi: 10.1016/S1474-4422(09)70358-8
Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol. 2010;67(2):221–229. doi: 10.1002/ana.21871
Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992;86(6):1902–1908. doi: 10.1161/01.cir.86.6.1902
Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356(9242):1648–1651. doi: 10.1016/s0140-6736(00)03160-3
Dowson A, Mullen MJ, Peatfield R, et al. Migraine intervention with STARFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117(11):1397–1404. doi: 10.1161/CIRCULATIONAHA.107.727271. Erratum in: Circulation. 2009;120(9):e71–72.
Mirza MR, González-Martín A, Graybill WS, et al. Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial. Cancer. 2023;129(12):1846–1855. EDN: AVVEJV doi: 10.1002/cncr.34706
Tobis JM, Charles A, Silberstein SD, et al. Percutaneous closure of patent foramen ovale in patients with migraine: The PREMIUM trial. J Am Coll Cardiol. 2017;70(22):2766–2774. EDN: YKCBPL doi: 10.1016/j.jacc.2017.09.1105
Kent DM, Thaler DE. RoPE study investigators. The risk of paradoxical embolism (RoPE) study: Developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke. Trials. 2011;12:185. EDN: MZWCEU doi: 10.1186/1745-6215-12-185
Headache classification committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. doi: 10.1177/0333102417738202
Pristipino C, Sievert H, D’Ascenzo F, et al. Evidence Synthesis Team; Eapci Scientific Documents and Initiatives Committee; International Experts. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019;40(38):3182–3195. doi: 10.1093/eurheartj/ehy649
Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 2001;56(1):20–28. doi: 10.1212/wnl.56.suppl_1.s20
Kumar P, Kijima Y, West BH, et al. The connection between patent foramen ovale and migraine. Neuroimaging Clin N Am. 2019;29(2):261–270. doi: 10.1016/j.nic.2019.01.006
Liboni W, Molinari F, Allais GB, et al. Patent foramen ovale detected by near-infrared spectroscopy in patients suffering from migraine with aura. Neurol Sci. 2008;29(Suppl 1): S182–185. doi: 10.1007/s10072-008-0920-7
Buse DC, Loder EW, Gorman JA, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: Results of the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2013;53(8):1278–1299. doi: 10.1111/head.12150
Anzola GP, Meneghetti G, Zanferrari C, et al. Is migraine associated with right-to-left shunt a separate disease? Results of the SAM study. Cephalalgia. 2008;28(4):360–366. doi: 10.1111/j.1468-2982.2008.01539.x
Khessali H, Mojadidi MK, Gevorgyan R, et al. The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache. JACC Cardiovasc Interv. 2012;5(6):682–687. doi: 10.1016/j.jcin.2012.03.013
Vigna C, Marchese N, Inchingolo V, et al. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: A casecontrol study. JACC Cardiovasc Interv. 2009;2(2):107–113. doi: 10.1016/j.jcin.2008.10.011
Rigatelli G, Dell’Avvocata F, Ronco F, et al. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. JACC Cardiovasc Interv. 2010;3(3):282–287. doi: 10.1016/j.jcin.2009.11.019
Kimmelstiel C, Gange C, Thaler D. Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study. Catheter Cardiovasc Interv. 2007;69(5):740–746. doi: 10.1002/ccd.21025
He Q, Zhang Y, Wang F, et al. Impact of right-to-left shunt and transcatheter closure on the clinical features of migraine. Int J Neurosci. 2020;130(3):270–275. EDN: FUAAQB doi: 10.1080/00207454.2019.1672681
Wintzer-Wehekind J, Horlick E, Ibrahim R, et al. Effect of clopidogrel and aspirin vs aspirin alone on migraine headaches after transcatheter atrial septal defect closure: One-year results of the CANOA randomized clinical trial. JAMA Cardiol. 2021;6(2):209–213. doi: 10.1001/jamacardio.2020.4297
Sommer RJ, Nazif T, Privitera L, Robbins BT. Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale. Neurology. 2018;91(22):1002–1009. doi: 10.1212/wnl.0000000000006572
Capodanno D, Valgimigli M, Byrne R, Kunadian V. European position paper on the management of patients with patent foramen ovale. Part II: Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions. Eur Heart J. 2021;42(16):1545–1553. doi: 10.1093/eurheartj/ehaa1070

Еще

Статья научная